Quinidine
is a
pharmaceutical
agent that acts as a
class I antiarrhythmic agent in the
heart. It is a
stereoisomer of
quinine, originally derived from the bark of the
cinchona tree.Like all other class I
antiarrhythmic agents,
quinidine primarily works by blocking the fast inward
sodium current (INa).
Quinidine's effect on INa
is known as a use dependent block.
This means that at higher heart rates, the block increases, while at lower heart
rates the block decreases. The effect of blocking the fast inward sodium current
causes the phase 0 depolarization of the
cardiac action potential to decrease (decreased Vmax).Quinidine also blocks the slowly
inactivating
tetrodotoxin-sensitive
Na current, the slow inward
calcium current (ICa), the rapid (IKr)
and slow (IKs) components of the delayed
potassium rectifier current, the inward potassium rectifier current (IKI),
the ATP-sensitive potassium channel (IKATP)
and Ito.The effect of
quinidine on the ion channels is to prolong the cardiac action potential,
thereby prolonging the QT interval on the surface
EKG.The half life of oral
quinidine is 6 to 8 hours, and it is eliminated by
the
cytochrome P450 system in the liver. About 20
percent is excreted unchanged via the kidneys.Qunidine-induced
thrombocytopenia (low platelet count) is mediated by the
immune system, and may lead to thrombocytic
purpura.